Full article (Clin Gastroenterol Hepatol 2014; 12: 177-86): http://ow.ly/sPKbi
My take on the most important parts of this Helicobacter pylori (HP) article:
- Success defined: curing HP ≥95% =excellent, curing HP ≥90% =good, acceptable ≥85%, and unsatisfactory <85%.
- “Because clarithromycin-containing triple therapy and 10-day sequential therapy are now only effective in special populations, they are considered obsolete.”
- The “preferred choices for Western countries” are the following
- 14-day concomitant therapy: PPI, amoxicillin 1 g, clarithromycin 500 mg, metronidazole -all twice daily
- 14-day bismuth quadruple therapy: PPI BID, bismuth BID, tetracycline 500 mg QID, metronidazole 500 mg TID
- 14-day hybrid sequential-concomitant therapy: 7 days of PPI-amoxicillin 1 g, followed by amoxicillin 1 g, clarithromycin 500 mg, metronidazole 500 mg for 7 days-all BID
Other useful points:
- Tetracycline is not available in many parts of the world and generally doxycycline is not an adequate substitute for tetracycline.
- Triple therapies are extremely sensitive to resistance of the third drug (eg. clarithromycin and metronidazole). The increase in resistance is making these regimens ineffective
- An online calculator can help predict which therapy to choose: https://hp-therapy.biomed.org/tw/ (need to know local resistance)
- Poor compliance is the other factor besides resistance that can undermine a well-constructed treatment regimen. Spending ample time educating patients about the need to take all of their medicines is crucial.
- Figure 1 on page 178 outlines the recommended treatment approach. Unfortunately, availability of susceptibility testing has been quite limited.
Take-home message: The authors emphasize using regimens that work locally and using the evidence that we have to choose the best treatments. However, given the resistance patterns, working on collaborating with laboratories to culture HP for susceptibility/resistance would be worthwhile to increase the likelihood of excellent outcomes.
Related blog links:
- Helicobacter pylori –useful advice | gutsandgrowth
- High Rates of Helicobacter Pylori Resistance | gutsandgrowth
Also noted: full text article online (from Kipp Ellsworth twitter feed): http://goo.gl/dD2ooF “Intestinal Transplantation: An Unexpected Journey” This is a succinct overview of intestinal transplantation’s progress and potential.
Disclaimer: These blog posts are for educational purposes only. Specific dosing of medications (along with potential adverse effects) should be confirmed by prescribing physician. This content is not a substitute for medical advice, diagnosis or treatment provided by a qualified healthcare provider. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a condition.